Health News

Shawnee Academy, a psychiatric residential treatment facility and private academic school for children and adolescents with special needs located inShawnee-on-Delaware, PA, has entered into a management agreement with Northwestern Management Services Com

BioMarin Pharmaceutical Inc. and La Jolla Pharmaceutical Company announced today that they have entered into an agreement to develop and commercialize Riquent,La Jolla's investigational drug for lupus nephritis, inthe United States,Europe and all other t

Onyx Pharmaceuticals, Inc. today announced that it has acquired an option to license rights to SB1518, an orally available, potent, and selective inhibitor of Janus Kinase 2 , and SB1578, also a JAK2 inhibitor, from S*BIO Pte Ltd based inSingapore. Under

Patients with advanced Parkinson disease who received deep brain stimulation treatment had more improvement in movement skills and quality of life after six months than patients who received other medical therapy, but also had a higher risk of a serious

Warner Chilcott Limited today announced that it has signed an agreement with Dong-A PharmTech Co. Ltd., based in Korea, to develop and market their orally-administered udenafil product, a phosphodiesterase type 5 inhibitor for the treatment of erectile d

We live in a 'free society' that should allow its citizens the right to choose the type of healthcare they deem best for themselves.

Medarex, Inc. announced today that it is scheduled to present at the 27th Annual J.P. Morgan Healthcare Conference at 8:30 a.m. Pacific Time on Tuesday, January 13, 2009. The event will be webcast live and will be available in the Investor Relations sect

Pharmacyclics, Inc. today announced that in preparation of further equity offerings, Robert W. Duggan & Associates made an unsecured loan to Pharmacyclics, Inc. on December 30, 2008, in the amount of $5,000,000. As of December 31, 2008, the company's